|
Additional Lots Added: Voluntary Nationwide Recall of 21 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 Grams Due to Possibility of... |
|
American CryoStem to Collaborate With Rutgers University on Adipose-Derived Stem Cell Research Focus on Studying, Developing and Commercializing Innovative New Cellular Therapies to Address $5 Billion Wound Care Market Using Company's ADSCs and |
|
AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease AbbVie secures exclusive option to acquire global rights to ALV003ALV003 has the potential to be the first therapy to treat celiac disease |
|
Drug development firm Redx Pharma is to take... |
|
Smiths Medical Offers Innovative Technology that Reduces the Need for Occlusion De-clotting Medication |
|
Medivir: U.S. FDA grants priority review to Simeprevir for combination treatment of genotype 1 chronic hepatitis C |
|
Sorin Group Announces FDA Approval and U.S. Launch of SMARTVIEW(TM) Remote Monitoring Solution for Patients with Implanted Cardiac Defibrillators |
|
NPA Asks FDA to Issue Revised Draft Guidance on NDI Ingredient Identity |
|
Additional Lots Added: Voluntary Nationwide Recall of 21 Lots of Piperacillin and Tazobactam for Injection, USP 40.5 Grams Due to Possibility of... |
|
FDA accepts Seattle Genetics Adcetris application |
|
Novartis drug Ilaris approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis |
|
Attorney General Conway and Colleagues Urge FDA to Place Black Box Warning on Opioids |
|
UPDATE: First US Patent for Vaccine Treatment of Obesity Is Awarded to Braasch Biotech LLC |
|
US evokes emergency act to keep flu at bay |
|
IMS Health Study Points to a Declining Cost Curve for U.S. Medicines in 2012; Total Real Per Capita Spending on Medicines Fell 3.5 Percent; Fewer Doctor Office Visits and Non-Emergency Hospital Admissions; Prescription Use Down 0.1 Percent |
|
Nearly 50% of Patients with Cardiac Device Infections Don’t Survive Beyond Three Years |
|
Geisinger Partners With Indivumed for Personalized Medicine Initiative |
|
Boston Scientific Wins CE Mark Approval for Rhythmia Mapping System |
|
Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing |
|
Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis MS in TOPIC Study Genzyme |
|
Data from GlaxoSmithKline Provide New Insights into Antibiotics Drugs and Therapies |
|
Once-daily AUBAGIO Delayed Onset of Clinically Definite Multiple Sclerosis MS in TOPIC Study Genzyme |
|
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402 Teva Pharmaceutical Industries Ltd. |
|
Cold Chain Technologies Expands Into Latin America |
|
UPDATE: First US Patent for Vaccine Treatment of Obesity Is Awarded to Braasch Biotech LLC |
